- Home
- NBTX vs AMPX Comparison
NBTX vs AMPX Comparison
Compare NBTX & AMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- AMPX
- Stock Information
- Founded
- NBTX 2003
- AMPX 2008
- Country
- NBTX France
- AMPX United States
- Employees
- NBTX N/A
- AMPX N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- AMPX Industrial Machinery/Components
- Sector
- NBTX Health Care
- AMPX Miscellaneous
- Exchange
- NBTX Nasdaq
- AMPX Nasdaq
- Market Cap
- NBTX 868.8M
- AMPX 952.3M
- IPO Year
- NBTX 2020
- AMPX N/A
- Fundamental
- Price
- NBTX $21.04
- AMPX $13.27
- Analyst Decision
- NBTX Strong Buy
- AMPX Strong Buy
- Analyst Count
- NBTX 1
- AMPX 7
- Target Price
- NBTX $8.00
- AMPX $12.67
- AVG Volume (30 Days)
- NBTX 112.7K
- AMPX 10.1M
- Earning Date
- NBTX 09-30-2025
- AMPX 11-06-2025
- Dividend Yield
- NBTX N/A
- AMPX N/A
- EPS Growth
- NBTX N/A
- AMPX N/A
- EPS
- NBTX N/A
- AMPX N/A
- Revenue
- NBTX $11,930,711.00
- AMPX $44,837,000.00
- Revenue This Year
- NBTX N/A
- AMPX $177.55
- Revenue Next Year
- NBTX $74.67
- AMPX $171.83
- P/E Ratio
- NBTX N/A
- AMPX N/A
- Revenue Growth
- NBTX N/A
- AMPX 260.92
- 52 Week Low
- NBTX $2.76
- AMPX $1.11
- 52 Week High
- NBTX $22.51
- AMPX $13.91
- Technical
- Relative Strength Index (RSI)
- NBTX 71.69
- AMPX 71.95
- Support Level
- NBTX $19.11
- AMPX $10.05
- Resistance Level
- NBTX $22.64
- AMPX $13.21
- Average True Range (ATR)
- NBTX 1.64
- AMPX 1.03
- MACD
- NBTX 0.63
- AMPX 0.17
- Stochastic Oscillator
- NBTX 83.03
- AMPX 74.16
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About AMPX Amprius Technologies Inc.
Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.